Springs Rehabilitation At Brandywine | |
505 Greenbank Road, Wilmington, Delaware 19808 | |
(302) 998-0101 | |
Name | Springs Rehabilitation At Brandywine |
---|---|
Location | 505 Greenbank Road, Wilmington, Delaware |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 169 |
Occupancy Rate | 66.8% |
Medicare ID (CCN) | 085004 |
Legal Business Name | Brandywine Nursing And Rehabilitation Inc |
Ownership Type | For Profit - Individual |
NPI Number | 1063419331 |
Organization Name | BRANDYWINE CONVALESCENT HOME, INC. |
Address | 505 Greenbank Rd, Wilmington, DE 19808 |
Phone Number | 302-998-0101 |
News Archive
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
PatientKeeper®, Inc., the leading provider of Physician Information Technology, announced today that Butler Health System of Butler, Pennsylvania selected PatientKeeper to help its organization meet the meaningful use criteria requirements established by the American Recovery and Reinvestment Act (ARRA). The implementation of PatientKeeper's Platform and Physician Portal, which is scheduled to roll-out in the first quarter of 2010, will extend physician accessibility and connectivity to over 200 physicians and significantly impact patient quality and care.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ .
› Verified 1 days ago
NPI Number | 1922689249 |
Organization Name | SPRINGS REHABILITATION AT BRANDYWINE LLC |
Doing Business As | CORAL SPRINGS REHAB AND HEALTHCARE CENTER |
Address | 505 Greenbank Rd, Wilmington, DE 19808 |
Phone Number | 302-998-0101 |
News Archive
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
PatientKeeper®, Inc., the leading provider of Physician Information Technology, announced today that Butler Health System of Butler, Pennsylvania selected PatientKeeper to help its organization meet the meaningful use criteria requirements established by the American Recovery and Reinvestment Act (ARRA). The implementation of PatientKeeper's Platform and Physician Portal, which is scheduled to roll-out in the first quarter of 2010, will extend physician accessibility and connectivity to over 200 physicians and significantly impact patient quality and care.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ .
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
PatientKeeper®, Inc., the leading provider of Physician Information Technology, announced today that Butler Health System of Butler, Pennsylvania selected PatientKeeper to help its organization meet the meaningful use criteria requirements established by the American Recovery and Reinvestment Act (ARRA). The implementation of PatientKeeper's Platform and Physician Portal, which is scheduled to roll-out in the first quarter of 2010, will extend physician accessibility and connectivity to over 200 physicians and significantly impact patient quality and care.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ .
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 3 |
Total Amount of Fines in Dollars | $89840 |
Number of Payment Denials | 0 |
Total Number of Penalties | 3 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.93 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.51 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 57.39 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.22 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.48 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.33 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.31 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.78 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 14.69 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 78.57 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.92 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 22.94 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.79 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 3.27 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 63.34 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.23 | 82.93 |
News Archive
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
PatientKeeper®, Inc., the leading provider of Physician Information Technology, announced today that Butler Health System of Butler, Pennsylvania selected PatientKeeper to help its organization meet the meaningful use criteria requirements established by the American Recovery and Reinvestment Act (ARRA). The implementation of PatientKeeper's Platform and Physician Portal, which is scheduled to roll-out in the first quarter of 2010, will extend physician accessibility and connectivity to over 200 physicians and significantly impact patient quality and care.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ .
› Verified 1 days ago
Kentmere Rehabilitation And Healthcare Center Location: 1900 Lovering Avenue, Wilmington, Delaware 19806 Phone: (302) 652-3311 | |
Willowbrooke Court At Country House Location: 4830 Kennett Pike, Wilmington, Delaware 19807 Phone: (302) 654-5101 | |
Springs Rehabilitation At Brandywine Location: 505 Greenbank Road, Wilmington, Delaware 19808 Phone: (302) 998-0101 | |
Regency Healthcare & Rehab Center Location: 801 N. Broom Street, Wilmington, Delaware 19806 Phone: (302) 654-8400 | |
Complete Care At Hillside Llc Location: 810 South Broom Street, Wilmington, Delaware 19805 Phone: (302) 652-1181 |